Marksans Pharma's UK subsidiary Relonchem secures marketing authorization from MHRA for Metformin tablets
The approvals cover: Metformin Hydrochloride Relonchem 500 mg Prolonged Release Tablets
Metformin Hydrochloride Relonchem 750 mg Prolonged Release Tablets
Metformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets
Metformin is among the most widely prescribed medications for the treatment of type 2 diabetes, playing a crucial role in blood sugar management. With this authorization, Relonchem will be able to expand its presence in the UK market and further strengthen Marksans Pharma's position in the global anti-diabetic segment.
Headquartered in Mumbai, Marksans Pharma operates manufacturing facilities in India, the USA, and the UK, all of which are approved by global regulators including USFDA, UKMHRA, and TGA. The company has a diversified product portfolio spanning cardiovascular, central nervous system, anti-diabetic, pain management, gastroenterology, and anti-allergy therapies.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Clean and harmonised CRM data vital for AI model training
As healthcare entities move towards the deployment of artificial intelligence (AI) models to streamline patient engagement, being acquitted of good customer relationship management (CRM) system data is of rising importance, an expert has said. In April 2025, the UK National Health Service (NHS) released guidance on the importance of using high-quality data in training AI models. The guidance highlighted that poor quality data can lead to unintended biases and other inaccuracies that may stymy the effectiveness of AI models used for varying functions in healthcare systems. CRM data includes information on patient demographics, individuals' medical history, insurance information, billing details, and more. The consolidation of this data is intended to improve patient engagement, personalise care, and track individuals' medical history. A 2022 report indicated that revenue streams from 44% of healthcare respondents were directly affected bypoor quality CRM data. In addition, 69% of respondents said their organisations did not pursue or complete potentially valuable initiatives due to low-quality CRM data. According to Rachel Mak-McCully, senior data scientist at digital twin developer the cleaning and harmonisation of CRM datasets is not an area that is given enough consideration – despite its significant influence on AI models being deployed in healthcare. 'In thinking about clean data, there's a few issues, including how accurate and comprehensive the data is,' Mak-McCully told Medical Device Network. 'In the US, we have a very fractured medical system, so the information that you get about someone may be quite fractured.' Fractured data can relate to data that is missing because it hasn't been collected at the same time or stored together, Mak-McCully said, or in the sense that it's been measured in different ways. 'Imagine the data cleaning process as a spreadsheet. You might have a lot of different columns that are named differently, but they're the same thing. You want to make sure that all of those are harmonised into the same column,' Mak-McCully said. 'And you want to make sure that the units that you're measuring across a range of different data sources are the same. The ultimate goal is to have a clean, tabular dataset at the end that incorporates all relevant sources of data, so that a single, clean source of data can be used to train your AI model.' Mak-McCully concludes that while there is a lot of talk about the performance of AI models in healthcare and other areas, such as the new benchmarks that have been made, very few people talk about the underlying data. 'For us to clearly communicate what it is that we're doing, the implications of that and for people to understand how data is used, particularly in healthcare, is a really important conversation.' "Clean and harmonised CRM data vital for AI model training" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Journals
25 minutes ago
- Business Journals
Soho House going private in deal involving Ashton Kutcher
Soho House & Co. Inc., the exclusive members-only club used by many Austinites to network and socialize, is going private in a deal valued at $2.7 billion. An investor group led by New York-based MCR Hotels will acquire all outstanding shares of Soho House, which has dozens of locations around the world, according to an Aug. 18 announcement. Billionaire Ron Burkle, the executive chairman of Soho House and controlling shareholder, will roll over his stake, along with other existing shareholders. The deal, which has an enterprise value of about $2.7 billion, ends a monthslong debate over the future of Soho House, according to The Wall Street Journal. Dan Loeb and his hedge fund Third Point had been pushing the board to consider outside bidders in an effort to get a higher price, WSJ reported. GET TO KNOW YOUR CITY Find Local Events Near You Connect with a community of local professionals. Explore All Events Shares (NYSE: SHCO) soared 16% to $8.84 on the news on the morning of Aug. 18. Soho House's IPO launched at $14 a share in 2021. Stockholders will receive $9 a share for the company's outstanding public stock, according to the announcement. Additionally, a consortium of strategic investors led by actor Ashton Kutcher will provide new equity capital, and Kutcher will join the Soho House board after the deal closes. Citi is serving as financial advisor to the company, and Sidley Austin LLP is serving as legal counsel. Canaccord is serving as financial advisor to MCR. expand Soho House Austin Soho House Austin Soho House Austin opened in 2021 in the Music Lane development on South Congress Avenue. It's been cited by many business leaders as their favorite place in Austin to work, socialize and network. It has a pool, dining, club and bar space and 46 bedrooms, according to its website. Memberships cost anywhere from about $3,000 to almost $6,000 a year. People under the age of 27 pay less. Last year, Michelin Guide launched its first-ever Michelin Keys selection dedicated to North American hotels. Soho House Austin received a key, along with other local hotels such as Arrive Austin, Austin Proper Hotel, Fairmont Austin Gold Experience, Hotel Saint Cecillia, Hotel ZaZa Austin and The Heywood Hotel.
Business Wire
25 minutes ago
- Business Wire
APPLE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apple Inc.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ('KSF'), announces that KSF has commenced an investigation into Apple Inc. ('Apple' or the 'Company') (NasdaqGS: AAPL). On March 7, 2025, the Company disclosed that it was indefinitely delaying several AI-based Siri features due to development delays, pushing their release to sometime "in the coming year." Then, on June 9, 2025, the Company hosted its Worldwide Developer Conference for 2025, failing to announce any substantive updates regarding advanced Siri features, which resulted in negative reactions from analysts and media outlets. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information in violation of federal securities laws, which remains ongoing. KSF's investigation is focusing on whether Apple's officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If you have information that would assist KSF in its investigation, or have been a long-term holder of Apple shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ( or visit to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit
